Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
CalciTech Ltd. (CLKTF)
Geneva, CH
CalciTech Ltd. specializes in the development and market introduction of synthetic calcium carbonate (SCC) across Europe. Its SCC is sustainably produced by repurposing industrial by-products such as waste lime and capturing harmful atmospheric carbon dioxide. This brilliant white pigment finds extensive use across various industrial sectors, including paper manufacturing, polymers, paints, and the food and pharmaceutical industries. For the paper industry, the company offers a trio of SCC products specifically tailored for its needs: CalciLS, engineered for optimal light diffusion; CalciSG, designed for imparting a lustrous finish to high-grade printing and writing papers; and CalciRG, a performance-enhancing additive aimed at the rotogravure market. Beyond paper applications, CalciTech also provides CalciSP, designed for the food, pharmaceutical, and cosmetics industries, and CalciRC, which addresses polymer-based requirements in materials like plastics, sealants, rubber, and adhesives. Previously trading as Kemgas Ltd., the company adopted its current name, CalciTech Ltd., in July 2000. This change reflected a strategic shift towards the manufacturing and commercialization of SCC. Established in 1978, CalciTech Ltd. is headquartered in Geneva, Switzerland.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -99.89% | -98.61% | -99.99% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Chemicals - Specialty: +4.7%-51.0% Q4'07: -6.7% (vs Q1'06)
-
EPS growth Chemicals - Specialty: +13.2%+55.0% ★ Q4'07: +69.1% (vs Q1'06)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-537.5% Q4'07: -1,942.9% (vs Q1'06)
-
EBIT margin Chemicals - Specialty: +8.8%-586.5% Q4'07: -2,557.1% (vs Q1'06)
-
ROIC Chemicals - Specialty: +5.6%-6.2%
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q4'07: +17.9% (vs Q1'06)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×-8.16× Q4'07: -1.26× (vs Q1'06)
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Roger A. Leopard | Chief Executive Officer, President, Principal Financial Officer, Principal Accounting Officer and Director | 60.0K | male |
| Baron Shortt | Director of Corporation Communications | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CLKTF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
